Specifically, DCs from patients with rheumatoid arthritis (RA) exhibit an increased expression of CD14 and CD16 proteins on their surface, indicating a shift towards a pro-inflammatory phenotype. Here, FCGR3A is linked to rheumatoid arthritis.